Owkin is pioneering advanced AI to automate biopharmaceutical R&D and support clinical research. Their AI, K Pro, is designed to explore and formulate hypotheses beyond human capabilities, aiming to achieve a Biological Artificial SuperIntelligence.
À propos de Owkin
Owkin develops AI technologies that automate R&D processes in the biopharmaceutical industry. Their AI platform, K Pro, leverages a rich multimodal patient data network and collaborates with a global network of oncologists and biologists to enhance clinical research and decision-making in healthcare.
Enterprise Knowledge AssistantsResearch AgentsData Analysis Agents
Fonctionnalités
Prioritize therapeutic targets using statistical evidence from TCGA and MOSAIC datasets
Evaluate target tractability, safety profiles, and therapeutic potential using curated databases
Identify distinct patient populations based on multi-omics profiles and clinical outcomes
Generate publication-ready statistical reports for gene/target assessment and biomarker prioritization
Test biomarkers and hypotheses across bulk RNA-seq, single-cell, spatial, and clinical data
Integrate genomic, transcriptomic, and immune data to predict treatment response
Orchestrate specialized AI skills dynamically to solve drug discovery challenges
Deploy AI tools and analyses securely with ISO27001 and GDPR compliance